Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
The Clinical Biochemist. Reviews|June 21, 2008
Common and rare gene variants affecting plasma LDL cholesterolJohn R Burnett, Amanda J HooperCurrent Opinion in Lipidology|December 21, 2012
Recent developments in the genetics of LDL deficiencyAmanda J Hooper, John R BurnettCurrent Atherosclerosis Reports|May 1, 2014
Update on primary hypobetalipoproteinemiaAmanda J Hooper, John R BurnettExpert Opinion on Investigational Drugs|June 26, 2012
Dalcetrapib , a cholesteryl ester transfer protein modulatorAmanda J Hooper, John R BurnettExpert Opinion on Biological Therapy|December 18, 2012
Anti-PCSK9 therapies for the treatment of hypercholesterolemiaAmanda J Hooper, John R BurnettCurrent Opinion in Molecular Therapeutics|January 15, 2010
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiencyJohn R Burnett, Amanda J HooperExpert Opinion on Investigational Drugs|December 24, 2011
Anacetrapib, a cholesteryl ester transfer protein inhibitorAmanda J Hooper, John R BurnettExpert Opinion on Investigational Drugs|October 10, 2023
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatmentJohn R Burnett, Amanda J HooperFree Radical Biology & Medicine|June 19, 2015
Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemiaJohn R Burnett, Amanda J HooperExpert Opinion on Investigational Drugs|January 8, 2011
Mipomersen, an antisense apolipoprotein B synthesis inhibitorDamon A Bell, Amanda J Hooper, John R BurnettPageof 14